Results 261 to 270 of about 466,412 (376)

Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand. [PDF]

Eur J Health Econ, 2023
Claflin S, Campbell JA, Norman R, Mason DF, Kalincik T, Simpson-Yap S, Butzkueven H, Carroll WM, Palmer AJ, Blizzard CL, van der Mei I, Henson GJ, Taylor BV.   +12 more
europepmc   +1 more source

Signs of Cortical Inflammation in Migraine Measured with Quantitative Magnetic Resonance Imaging: A Registry for Migraine (REFORM) Study

Annals of Neurology, Volume 97, Issue 6, Page 1168-1179, June 2025.
Objective The involvement of cortical inflammation in migraine, particularly migraine with aura, has been a subject of considerable interest, but has proved challenging to demonstrate. We aimed to detect and characterize signs of cortical inflammation in adults with migraine using a novel, multimodal magnetic resonance imaging (MRI) technique.
Rune H. Christensen, Håkan Ashina, Haidar M. Al‐Khazali, Mario Ocampo‐Pineda, Reza Rahmanzadeh, Nouchine Hadjikhani, Cristina Granziera, Faisal Mohammad Amin, Messoud Ashina   +8 more
wiley   +1 more source

Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS). [PDF]

Neurol Int, 2021
Berger AA, Sottosanti ER, Winnick A, Izygon J, Berardino K, Cornett EM, Kaye AD, Varrassi G, Viswanath O, Urits I.   +9 more
europepmc   +1 more source

Validation of the Automatic Thoughts Questionnaire-18 item- Multiple Sclerosis-Arabic (ATQ-18-MS-Ar) among multiple sclerosis patients. [PDF]

, 2016
Muaweah Ahmad Alsaleh, Amani Kubitary
openalex   +1 more source

Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics

Annals of Neurology, EarlyView.
Objectives Rapid advances in transcriptomics have driven efforts to identify deregulated pathways in multiple sclerosis (MS) tissues, though many detected differentially expressed genes are likely false positives, with only a small fraction reflecting actual pathological events. Robust, integrative methods are essential for accurately understanding the
Gianmarco Abbadessa, Ai Nagano, Simon Hametner, Owain Howell, David Owen, Artemis Papadaki, Prashant Srivastava, Simona Bonavita, Roberta Magliozzi, Richard Reynolds, Mie Rizig, Richard Nicholas   +11 more
wiley   +1 more source

Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS). [PDF]

Mult Scler Int, 2021
Mirmosayyeb O, Barzegar M, Afshari-Safavi A, Nehzat N, Heidari A, Emami P, Shaygannejad V.   +6 more
europepmc   +1 more source

'Outside-in' demyelination in MS [PDF]

Nature Reviews Neurology, 2012
openaire   +3 more sources

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study

Annals of Neurology, EarlyView.
Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (UK) hospital‐based observational cohort, modeled data were obtained from 621 relapsing–remitting multiple sclerosis ...
Paolo Antonio Muraro, Antonio Zito, Alessio Signori, Maria Pia Sormani, Eleonora Rigoni, Federica Pollidoro, Roberto Bergamaschi, Alice Mariottini, Omar Malik, Ashwini Nandoskar, Victoria Singh‐Curry, Varun Mehra, Majid Kazmi, Ian Gabriel, Eli Silber, Richard Nicholas, Antonio Scalfari   +16 more
wiley   +1 more source

11. Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO)

, 2013
Kazuo Fujihara
openalex   +2 more sources

Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS) [PDF]

, 2017
Gustavo Saposnik, Ángel Pérez Sempere, Daniel Prefasi, Daniel Selchen, Christian C. Ruff, Jorge Mauriño, Philippe N. Tobler   +6 more
openalex   +1 more source